We are pleased to announce that Dr. Esther Wenzel will be speaking at ESTIV 2026 in the session:

Session 6 – Track B: Replacing animals in therapeutic monoclonal antibody approvals
📅 Wednesday, July 1, 2026
🕘 09:00–10:30

The presentation will explore opportunities for implementing animal-free antibodies in testing strategies and discuss their potential to support the replacement of animal-derived reagents in research, development, and quality control workflows.

Our team will be present throughout the conference and welcomes discussions on animal-free antibodies, replacement strategies, and the transition toward more animal-free laboratory practices.

We look forward to connecting with colleagues and partners in Maastricht at ESTIV 2026.